Anticoagulant rodenticides competitively inhibit vitamin K epoxide reductase<sup>4</sup>, preventing the recyling of vitamin K and depriving the liver of the active, reduced form of the vitamin<sup>1-6</sup>. Activation of factors II, VII, IX and X ceases, but there is a quantity of these already in the circulation that are not affected. A time-lag therefore exists between ingestion of anticoagulant rodenticide and the clinical manifestation of toxicity (unchecked haemorrhage), while the supply of still-viable, vitamin K-dependent clotting factors reach the end of their life span. This delay is around 5 days in length<sup>3</sup>, and may mean that patients present late to veterinary practices after intoxication<sup>6</sup>. | Anticoagulant rodenticides competitively inhibit vitamin K epoxide reductase<sup>4</sup>, preventing the recyling of vitamin K and depriving the liver of the active, reduced form of the vitamin<sup>1-6</sup>. Activation of factors II, VII, IX and X ceases, but there is a quantity of these already in the circulation that are not affected. A time-lag therefore exists between ingestion of anticoagulant rodenticide and the clinical manifestation of toxicity (unchecked haemorrhage), while the supply of still-viable, vitamin K-dependent clotting factors reach the end of their life span. This delay is around 5 days in length<sup>3</sup>, and may mean that patients present late to veterinary practices after intoxication<sup>6</sup>. |